HSCA Response to the U.S. Trade Representative’s Section 301 Investigation of Acts, Policies, and Practices of Certain Economies Relating to Structural Excess Capacity and Production in Manufacturing Sectors
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments to the Office of the U.S. Trade Representative on its Section 301 investigation into structural excess capacity and production in manufacturing sectors.
Click here to view the full response.
Lear MoreHSCA Comments on the Centers for Medicare & Medicaid Services Advance Notice of Proposed Rulemaking on Ensuring Safety Through Domestic Security With Made in America PPE and Essential Medicine Procurement by Medicare Participating Hospitals
On behalf of the Healthcare Supply Chain Association (HSCA), which represents the nation’s leading traditional healthcare group purchasing organizations (GPOs), we appreciate the opportunity to provide comments to the Centers for Medicare and Medicaid Services (CMS) regarding its Advance Notice of Proposed Rulemaking (ANPRM) on Ensuring Safety Through Domestic Security With Made in America Personal Protective Equipment (PPE) and Essential Medicine [CMS-1516-ANPRM].
Click here to view the full response.
Lear MoreTestimony of HSCA CEO Angie Boliver before the Subcommittee on Health, House Committee on Energy and Commerce
Thank you for the opportunity to discuss the important role of traditional healthcare group purchasing organizations (GPOs) in lowering costs in the pharmaceutical supply chain.
Click here to view the full response.
Lear More